glp-1 parkinson's disease lancet Receptor Agonists: A New Treatment in The glucagon-like peptide 1 (GLP)

Rotate injection sites

Though not yet FDA approved, clinical trials show it may help people lose more weight than current treatments

(laughs) David Kellner, MD: I would say the most common side effects with these medications are gastrointestinal, so nausea, diarrhea, constipation, acid reflux, and this is especially during dose increases

"That's when I started seeing things in the chat," he says of the app's patient forum feature

For the Media Please cite this data as National Poison Data System, Americas Poison Centers. Any and all print, digital, social, or visual media using this data must include the following: You can reach your local poison center by calling Poison Help at 1-800-222-1222

DOI: 10.1172/JCI194751.